Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 7, No 2 (2015) The fifth anniversary of clinical use of new oral anticoagulants in non-valvular atrial fibrillation Abstract  similar documents
A. V. Fonyakin
"... a new page in oral anticoagulant therapy aimed at preventing thromboembolic events in AF. Dabigatran ..."
 
Vol 4, No 1 (2012) New possibilities in the prevention of stroke in atrial fibrillation Abstract  similar documents
Vladimir Anatolyevich Parfenov, S V Verbitskaya
"... and warfarin. The trial has indicated that the use of dabigatran in a dose of 150 mg twice daily results ..."
 
Vol 7, No 4 (2015) Topical issues of the efficiency and safety of using the first direct thrombin inhibitor in real clinical practice Abstract  similar documents
A. V. Fonyakin
"... aspects of the efficiency and safety of using the first direct thrombin inhibitor dabigatran etexilate ..."
 
Vol 6, No 2 (2014) Dabigatran etexilate for nonvalvular atrial fibrillation in real practice and promises for its use to prevent stroke Abstract  similar documents
A.V. Fonyakin
"... , one of which is dabigatran. A wealth of world clinical experience with dabigatran has confirmed its ..."
 
Vol 6, No 3 (2014) The risk factors and prevention of stroke in atrial fibrillation Abstract  similar documents
V. A. Parfenov, S. V. Verbitskaya
"... randomized trials that show that novel oral anticoagulants (dabigatran, rivaroxaban, apixaban) are as good ..."
 
Vol 6, No 2S (2014): Special issue "Stroke" Secondary prevention of stroke in atrial fibrillation, use of apixaban: ARISTOTLE, AVERROES studies Abstract  similar documents
V.A. Parfenov, S.V. Verbitskaya
"... – dabigatran. Presented results ARISTOTLE study, where have defined preference apixaban vs warfarin ..."
 
Vol 8, No 4 (2016) GLOBAL CLINICAL PRACTICE AND PERSONALIZED CHOICES FOR ORAL ANTICOAGULANT THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Fonyakin, L. A. Geraskina
"... anticoagulant therapy for the prevention of thromboembolic events in AF. Dabigatran etexilate is the first DOAC ..."
 
Vol 5, No 2 (2013) Dabigatran experience in primary and secondary prevention of cardioembolic stroke Abstract  similar documents
Maksim Alekseyevich Domashenko, M Yu Maksimova, D Z Korobkova, M E Gafarova
"... The review of novel oral anticoagulants (dabigatran, rivaroxaban and apixaban) in stroke prevention ..."
 
Vol 8, No 1 (2016) Hemorrhagic stroke and oral anticoagulants: What is to be done? Abstract  similar documents
M. A. Domashenko
"... discusses medical treatment in patients with HS during therapy with vitamin K antagonists (warfarin ..."
 
Vol 4, No 3 (2012) A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation Abstract  similar documents
Andrei Viktorovich Fonyakin, L A Geraskina
"... in the prevention of thromboembolic events in AF. More than 60 years, only warfarin and other vitamin K antagonists ..."
 
Vol 5, No 2S (2013): Special issue "Stroke" Current approaches to antithrombotic therapy in patients with cardioembolic stroke Abstract  similar documents
Oleg Ivanovich Vinogradov, A N Kuznetsov, N V Rybalko
 
Vol 6, No 4 (2014) Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation Abstract  similar documents
A. V. Fonyakin
"... anticoagulants (NOACs), such as dabigatran, rivaroxaban, and apixaban. World clinical experience with NOACs in AF ..."
 
Vol 10, No 3 (2018) Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy Abstract  similar documents
S. N. Yanishevsky
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy Abstract  similar documents
S. N. Yanishevsky
 
Vol 6, No 1 (2014) Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations Abstract  similar documents
A.V. Fonyakin, L.A. Geraskina
"... and evaluates the potential of rivaroxaban as an alternative to warfarin. Rivaroxaban is shown to be a promising ..."
 
Vol 2, No 2 (2010) Clinical experience in using cereton in ischemic stroke and dyscirculatory encephalopathy Abstract  similar documents
L. P. Ponomareva, N. F. Timoshkina, L. N. Sarantseva, A. A. Bulanov
"... , which is based on the normalization of blood pressure and the use of antiplatelet agents or warfarin ..."
 
1 - 16 of 16 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)